Segmented information |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Segmented information | |
| Segmented information |
18.Segmented information The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia related diseases. As the operations comprise a single reporting segment, amounts disclosed also represent segment amounts. All long-term assets of the Company are located in Canada. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The disclosure of operating segments. [Refer: Operating segments [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|